Skip to content

Clinical trials

Phase 2 Breast Diseases trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Breast Diseases Phase: Phase 2 Clear all

11 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20081
20091
20111
20121
20181
20192
20201
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed4
Unknown status3
Recruiting2
Terminated1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Faculdade de Medicina do ABC1
Fujian Cancer Hospital1
Fuzhou General Hospital1
Hanlim Pharm. Co., Ltd.1
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.1
Maastricht University Medical Center1
Peking Union Medical College Hospital1
Pfizer1
Sun Yat-sen University1
Susanne Crocamo1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Breast Diseases11
Breast Neoplasms10
Neoplasms3
Neoplasms by Site3
Fatigue1
Neoplasm Metastasis1
Signs and Symptoms1
Skin Diseases1

Trials

Showing 51 to 11 of 11. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.